Brief: Matinas Biopharma Reports Q1 Loss Per Share Of $0.03
May 10 (Reuters) - Matinas BioPharma Holdings Inc MTNB.A :
* MATINAS BIOPHARMA REPORTS FIRST QUARTER 2021 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
* Q1 LOSS PER SHARE $0.03
* Q1 EARNINGS PER SHARE ESTIMATE $-0.03 -- REFINITIV IBES
DATA
* BELIEVES THAT CASH ON HAND IS SUFFICIENT TO FUND
OPERATIONS INTO
2024.
Source text for Eikon: ID:nGNX1bQhZH
Further company coverage: MTNB.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Matinas BioPharma Holdings
See all newsBrief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing
Brief: Matinas Biopharma Holdings Inc Keith Kucinski Resigns As CFO Effective January 17, 2026
Brief: Matinas Biopharma Holdings Inc - CFO Keith Kucinski Resigns Effective January 17, 2026 - SEC Filing
Brief: Matinas Biopharma Holdings Eric Ende Resigns As Chairman Of Matinas Biopharma
Brief: Matinas BioPharma Appoints Seasoned Biotech Leaders To Board Of Directors